|Company name||Nordion Inc(USA)|
|Live stock price||[stckqut]NDZ[/stckqut]|
|P/E compared to competitors||Good|
|Confident Investor Rating||Fair|
|Target stock price (TWCA growth scenario)||$15.91|
|Target stock price (averages with growth)||$50.99|
|Target stock price (averages with no growth)||$70.46|
|Target stock price (manual assumptions)||$10.12|
The following company description is from Google Finance: http://www.google.com/finance?q=ndz
Nordion Inc. (Nordion) is a global health science company, engaged providing products and services used for the prevention, diagnosis and treatment of disease. The Company’s business segments include Sterilization Technologies and Medical Isotopes as well as certain corporate functions and activities reported as Corporate and Other. On July 13, 2013, BTG Plc announced that it has completed the acquisition of Targeted Therapies division from Nordion Inc.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Nordion Inc(USA) as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.
For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.